Clinical Trial

A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This is a multicenter, open-label, phase I/Ⅱ study to evaluate the safety, efficacy, and pharmacokinetic (PK)/pharmacodynamic(PD) characteristics of HY0001a for injection in participants with advanced solid tumors.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-07; most recent amendment 2026-03-05.
Status change: Withdrawn → Recruiting 2026-03-05
Status change: Not Yet Recruiting → Withdrawn 2025-11-24
Trial Details
NCT Number NCT07069062
Lead Sponsor Sichuan Huiyu Pharmaceutical Co., Ltd
Conditions Solid Tumor
Enrollment 261 participants
Start Date 2025-07-21
Primary Completion 2027-06 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-09